Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins - Tam,S.H.; Sassoli,P.M.; Jordan,R.E.; Nakada,M.T. (Circulation, 1998)